Literature DB >> 25439727

A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.

Rebecca Buchert1, Hasan Tawamie1, Christopher Smith2, Steffen Uebe1, A Micheil Innes3, Bassam Al Hallak4, Arif B Ekici1, Heinrich Sticht5, Bernd Schwarze6, Ryan E Lamont3, Jillian S Parboosingh3, Francois P Bernier3, Rami Abou Jamra7.   

Abstract

Rhizomelic chondrodysplasia punctata (RCDP) is a group of disorders with overlapping clinical features including rhizomelia, chondrodysplasia punctata, coronal clefts, cervical dysplasia, congenital cataracts, profound postnatal growth retardation, severe intellectual disability, and seizures. Mutations in PEX7, GNPAT, and AGPS, all involved in the plasmalogen-biosynthesis pathway, have been described in individuals with RCDP. Here, we report the identification of mutations in another gene in plasmalogen biosynthesis, fatty acyl-CoA reductase 1 (FAR1), in two families affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. Exome analyses revealed a homozygous in-frame indel mutation (c.495_507delinsT [p.Glu165_Pro169delinsAsp]) in two siblings from a consanguineous family and compound-heterozygous mutations (c.[787C>T];[1094A>G], p.[Arg263(∗)];[Asp365Gly]) in a third unrelated individual. FAR1 reduces fatty acids to their respective fatty alcohols for the plasmalogen-biosynthesis pathway. To assess the pathogenicity of the identified mutations, we transfected human embryonic kidney 293 cells with plasmids encoding FAR1 with either wild-type or mutated constructs and extracted the lipids from the cells. We screened the lipids with gas chromatography and mass spectrometry and found that all three mutations abolished the reductase activity of FAR1, given that no fatty alcohols could be detected. We also observed reduced plasmalogens in red blood cells in one individual to a range similar to that seen in individuals with RCDP, further supporting abolished FAR1 activity. We thus expand the spectrum of clinical features associated with defects in plasmalogen biosynthesis to include FAR1 deficiency as a cause of syndromic severe intellectual disability with cataracts, epilepsy, and growth retardation but without rhizomelia.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25439727      PMCID: PMC4225589          DOI: 10.1016/j.ajhg.2014.10.003

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Functions and biosynthesis of plasmalogens in health and disease.

Authors:  Pedro Brites; Hans R Waterham; Ronald J A Wanders
Journal:  Biochim Biophys Acta       Date:  2004-03-22

3.  MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata.

Authors:  A M Bams-Mengerink; C B L M Majoie; M Duran; R J A Wanders; J Van Hove; C D Scheurer; P G Barth; B T Poll-The
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

4.  An animal cell mutant with a deficiency in acyl/alkyl-dihydroxyacetone-phosphate reductase activity. Effects on the biosynthesis of ether-linked and diacyl glycerolipids.

Authors:  P F James; A C Lake; A K Hajra; L K Larkins; M Robinson; F G Buchanan; R A Zoeller
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

5.  Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor.

Authors:  A M Motley; E H Hettema; E M Hogenhout; P Brites; A L ten Asbroek; F A Wijburg; F Baas; H S Heijmans; H F Tabak; R J Wanders; B Distel
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

6.  Plasma and red blood cell fatty acids in peroxisomal disorders.

Authors:  A B Moser; D S Jones; G V Raymond; H W Moser
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

7.  Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.

Authors:  Mushfiquddin Khan; Jaspreet Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2008-06-07       Impact factor: 5.372

8.  Plasmalogens participate in very-long-chain fatty acid-induced pathology.

Authors:  Pedro Brites; Petra A W Mooyer; Leila El Mrabet; Hans R Waterham; Ronald J A Wanders
Journal:  Brain       Date:  2008-11-20       Impact factor: 13.501

9.  HomozygosityMapper--an interactive approach to homozygosity mapping.

Authors:  Dominik Seelow; Markus Schuelke; Friedhelm Hildebrandt; Peter Nürnberg
Journal:  Nucleic Acids Res       Date:  2009-05-21       Impact factor: 16.971

10.  GeneHub-GEPIS: digital expression profiling for normal and cancer tissues based on an integrated gene database.

Authors:  Yan Zhang; Shiuh-Ming Luoh; Lawrence S Hon; Robert Baertsch; William I Wood; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2007-06-01       Impact factor: 16.971

View more
  39 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

Review 2.  Antenatal manifestations of inborn errors of metabolism: biological diagnosis.

Authors:  Christine Vianey-Saban; Cécile Acquaviva; David Cheillan; Sophie Collardeau-Frachon; Laurent Guibaud; Cécile Pagan; Magali Pettazzoni; Monique Piraud; Antonin Lamazière; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.982

3.  De novo variants in MPP5 cause global developmental delay and behavioral changes.

Authors:  Noelle Sterling; Anna R Duncan; Raehee Park; David A Koolen; Jiahai Shi; Seo-Hee Cho; Paul J Benke; Patricia E Grant; Casie A Genetti; Grace E VanNoy; Jane Juusola; Kirsty McWalter; Jillian S Parboosingh; Ryan E Lamont; Francois P Bernier; Christopher Smith; David J Harris; Alexander P A Stegmann; A Micheil Innes; Seonhee Kim; Pankaj B Agrawal
Journal:  Hum Mol Genet       Date:  2020-12-18       Impact factor: 6.150

4.  Dysregulation of Plasmalogen Homeostasis Impairs Cholesterol Biosynthesis.

Authors:  Masanori Honsho; Yuichi Abe; Yukio Fujiki
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

5.  A missense allele of PEX5 is responsible for the defective import of PTS2 cargo proteins into peroxisomes.

Authors:  Muhammad Ali; Shahid Y Khan; Tony A Rodrigues; Tânia Francisco; Xiaodong Jiao; Hang Qi; Firoz Kabir; Bushra Irum; Bushra Rauf; Asma A Khan; Azra Mehmood; Muhammad Asif Naeem; Muhammad Zaman Assir; Muhammad Hassaan Ali; Mohsin Shahzad; Khaled K Abu-Amero; Shehla Javed Akram; Javed Akram; Sheikh Riazuddin; Saima Riazuddin; Michael L Robinson; Myriam Baes; Jorge E Azevedo; J Fielding Hejtmancik; S Amer Riazuddin
Journal:  Hum Genet       Date:  2021-01-02       Impact factor: 4.132

6.  Genetic Variations of Ultraconserved Elements in the Human Genome.

Authors:  Anamarija Habic; John S Mattick; George Adrian Calin; Rok Krese; Janez Konc; Tanja Kunej
Journal:  OMICS       Date:  2019-11

7.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

8.  1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.

Authors:  Dana S'aulis; Emily A Khoury; Morgan Zabel; William B Rizzo
Journal:  Mol Genet Metab       Date:  2020-08-12       Impact factor: 4.797

Review 9.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

10.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.